CN103189510B - Ttll4肽及包含它们的疫苗 - Google Patents

Ttll4肽及包含它们的疫苗 Download PDF

Info

Publication number
CN103189510B
CN103189510B CN201180053599.XA CN201180053599A CN103189510B CN 103189510 B CN103189510 B CN 103189510B CN 201180053599 A CN201180053599 A CN 201180053599A CN 103189510 B CN103189510 B CN 103189510B
Authority
CN
China
Prior art keywords
peptide
ttll4
seq
hla
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180053599.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN103189510A (zh
Inventor
中村佑辅
角田卓也
大泽龙司
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of CN103189510A publication Critical patent/CN103189510A/zh
Application granted granted Critical
Publication of CN103189510B publication Critical patent/CN103189510B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4202—Receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201180053599.XA 2010-09-07 2011-09-06 Ttll4肽及包含它们的疫苗 Expired - Fee Related CN103189510B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38061110P 2010-09-07 2010-09-07
US61/380,611 2010-09-07
PCT/JP2011/004987 WO2012032764A1 (en) 2010-09-07 2011-09-06 Ttll4 peptides and vaccines containing the same

Publications (2)

Publication Number Publication Date
CN103189510A CN103189510A (zh) 2013-07-03
CN103189510B true CN103189510B (zh) 2015-05-06

Family

ID=45810374

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180053599.XA Expired - Fee Related CN103189510B (zh) 2010-09-07 2011-09-06 Ttll4肽及包含它们的疫苗

Country Status (13)

Country Link
US (1) US20130224234A1 (enExample)
EP (1) EP2614146A4 (enExample)
JP (1) JP2013540419A (enExample)
KR (1) KR20130101529A (enExample)
CN (1) CN103189510B (enExample)
AU (1) AU2011300253B2 (enExample)
BR (1) BR112013005448A2 (enExample)
CA (1) CA2810636A1 (enExample)
MX (1) MX2013002303A (enExample)
RU (1) RU2013115434A (enExample)
SG (1) SG187847A1 (enExample)
TW (1) TW201210608A (enExample)
WO (1) WO2012032764A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2015123315A (ru) * 2012-11-25 2017-01-10 Зе Реджентс Оф Зе Юниверсити Оф Калифорния Пептиды, стимулирующие подкожный адипогенез
WO2015184125A1 (en) 2014-05-28 2015-12-03 The Regents Of The University Of California Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
CN111041028B (zh) * 2019-12-20 2024-05-17 陕西省人民医院 人ttll4基因的用途及相关产品

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004018667A1 (ja) * 2002-08-26 2004-03-04 Kirin Beer Kabushiki Kaisha ペプチド及びこれを含む医薬
WO2010023856A1 (en) * 2008-08-27 2010-03-04 Oncotherapy Science, Inc. Pancreatic cancer related gene ttll4
US7745391B2 (en) * 2001-09-14 2010-06-29 Compugen Ltd. Human thrombospondin polypeptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004092207A2 (en) * 2003-04-16 2004-10-28 Algonomics N.V. Respiratory syncytial virus (rsv) peptides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7745391B2 (en) * 2001-09-14 2010-06-29 Compugen Ltd. Human thrombospondin polypeptide
WO2004018667A1 (ja) * 2002-08-26 2004-03-04 Kirin Beer Kabushiki Kaisha ペプチド及びこれを含む医薬
WO2010023856A1 (en) * 2008-08-27 2010-03-04 Oncotherapy Science, Inc. Pancreatic cancer related gene ttll4

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Naturally Occurring Variants of Human T-cell Leukemia Virus Type I Tax Protein Impair Its Recognition by Cytotoxic Lymphocytes and the Transactivation Function of Tax;STEFAN NIEWIESK et al.;《JOURAL OF VIROLOGY》;19950430;第2651页 *

Also Published As

Publication number Publication date
WO2012032764A1 (en) 2012-03-15
EP2614146A1 (en) 2013-07-17
AU2011300253A1 (en) 2013-03-21
AU2011300253B2 (en) 2015-01-15
SG187847A1 (en) 2013-03-28
CN103189510A (zh) 2013-07-03
RU2013115434A (ru) 2014-10-20
EP2614146A4 (en) 2014-02-12
JP2013540419A (ja) 2013-11-07
MX2013002303A (es) 2013-10-28
KR20130101529A (ko) 2013-09-13
CA2810636A1 (en) 2012-03-15
BR112013005448A2 (pt) 2019-09-24
TW201210608A (en) 2012-03-16
US20130224234A1 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
CN105164256B (zh) Kntc2肽及包含它们的疫苗
CN102356155B (zh) Neil3肽及包含它的疫苗
CN104066746B (zh) Topk肽及包含它们的疫苗
CN102947325B (zh) Cdca5肽及包含它们的疫苗
CN102822193B (zh) 修饰的melk肽及包含它们的疫苗
CN104619833B (zh) Ube2t肽及包含它们的疫苗
CN103732743B (zh) Mphosph1肽及包含它们的疫苗
CN103620033A (zh) Sema5b肽及包含它们的疫苗
CN102459314B (zh) Ttk肽及包含它们的疫苗
CN103339253B (zh) Tomm34肽及包含它们的疫苗
CN103189510B (zh) Ttll4肽及包含它们的疫苗
CN102884190B (zh) Hjurp肽及包含它们的疫苗
CN102939379B (zh) Ect2肽及包含它们的疫苗
CN103282494B (zh) C18orf54肽及包含它们的疫苗
CN103270156B (zh) Wdhd1肽及包含它们的疫苗
CN102753567A (zh) Mybl2肽及包含它们的疫苗
JP2016502499A (ja) Ｓｅｍａ５ｂペプチドおよびそれを含むワクチン

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150506

Termination date: 20150906

EXPY Termination of patent right or utility model